Premium
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Numinus Wellness Comments on FDA Decision on New Drug Application for MDMA-Assisted Therapy for PTSD PR Newswire VANCOUVER, BC, Aug. 12, 2024 VANCOUVER, BC, Aug. 12, 2024 /PRNewswire/ - Numinus...
Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results PR Newswire VANCOUVER, BC, July 11, 2024 Q3 Fiscal 2024 Highlights Revenue of $4.3 million, a 1.9% decline over Q2 2024Gross...
Numinus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024 PR Newswire VANCOUVER, BC, July 10, 2024 VANCOUVER, BC, July 10, 2024 /PRNewswire/ - Numinus Wellness...
Numinus Wellness Announces Resignation of Director PR Newswire VANCOUVER, BC, June 24, 2024 VANCOUVER, BC, June 24, 2024 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the...
Plans name change to “Numinus Intelligence” leveraging its current revenue generating operations to AI-enable mental health clinics across the US The strategic combination merges MedBright’s...
Numinus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD PR Newswire VANCOUVER, BC, June 7, 2024 VANCOUVER, BC, June 7, 2024 /PRNewswire/...
Numinus Wellness Announces Voting Results From its Annual General Meeting of Shareholders PR Newswire VANCOUVER, BC, May 31, 2024 VANCOUVER, BC, May 31, 2024 /PRNewswire/ - Numinus Wellness Inc...
Numinus Wellness Receives Health Canada Approval for Study into Group Model for MDMA-Assisted Therapy PR Newswire VANCOUVER, BC, May 30, 2024 VANCOUVER, BC, May 30, 2024 /PRNewswire/ - Numinus...
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support PR Newswire VANCOUVER, BC, May 7, 2024 Numinus focuses resources on high-growth US operations, enhancing...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.03 | 0.035 | 0.03 | 129205 | 0.03 | CS |
| 4 | 0 | 0 | 0.03 | 0.035 | 0.03 | 177112 | 0.03201277 | CS |
| 12 | -0.015 | -33.3333333333 | 0.045 | 0.05 | 0.03 | 239598 | 0.0373921 | CS |
| 26 | -0.085 | -73.9130434783 | 0.115 | 0.115 | 0.03 | 382313 | 0.05665338 | CS |
| 52 | -0.135 | -81.8181818182 | 0.165 | 0.2 | 0.03 | 458588 | 0.093745 | CS |
| 156 | -0.61 | -95.3125 | 0.64 | 0.76 | 0.03 | 380260 | 0.23229294 | CS |
| 260 | -0.61 | -95.3125 | 0.64 | 0.76 | 0.03 | 380260 | 0.23229294 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
